1 / 24

AMOEBIASIS

AMOEBIASIS. HISTORY. 2yr 10mo girl Main Complaint: 7 days of loose, bloody diarrhoea and vomiting Lethargic and doesn’t feed well Previous history: Uneventful perinatal history No previous admissions to hospital Numerous clinic visits in preceding months for diarrhoea RVD status unknown

olinda
Download Presentation

AMOEBIASIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. AMOEBIASIS

  2. HISTORY • 2yr 10mo girl • Main Complaint: • 7 days of loose, bloody diarrhoea and vomiting • Lethargic and doesn’t feed well • Previous history: • Uneventful perinatal history • No previous admissions to hospital • Numerous clinic visits in preceding months for diarrhoea • RVD status unknown • No TB or other infectious contacts • No recent travel history / No significant family history • DIET: Never breastfed , Feeds on a family diet that includes mainly veg protein and carbohydrates. Denies traditional medicine ingestion.

  3. EXAMINATION • Growth paramoeters: • Weight: 11kg - 73% of expected for age • Length: 86cm – Below 3rd centile • Head Circ: 48cm – On 50th centile • Weight for height: Just below 3rd centile • Temp: 37.1 HR:135bpm RR:42/m BP:70mmHg syst • Distressed, ill-looking, pale, 7.5% dehydrated • Chest, CVS & CNS: Normal

  4. EXAMINATION • Abdomen: • Soft, distended abdomen with decreased bowel sounds • 3cm hepatomegaly – Firm, sharp edge, smooth surface non-displaced and not tender. • Fullness possibly a mass lesion extending from R flank across midline & tender to touch. • Normal hernial orifices and female genitalia • PR: No exterior abnormalities noted Irregular rectal mucosa Bloody, foul-smelling diarrhoea mixed with pus noted

  5. FBC: WCC: 3.12 Hb: 9.5 MCV: 80.1 Platelets: 127 Diff: Neut: 42.7% Mono: 17.8% Lymph: 35.7% Eosino: 1.8% Smear: Left shift + toxic granulation. CRP: 337 U&E: 129 / 2.6 / 91 / 24 / 3.4 / 38 LFT: Tbili: 13 Cbili: 1 TP: 46 Alb: 17 Glob: 29 ALP: 54 GGT: 32 ALT: 68 AST:81 Urine culture: Negative Stool culture: Negative Blood culture: Negative RVD Elisa: Positive CD4: 188 (4.62%) TB W/Up: Negative SPECIAL INVESTIGATIONS

  6. AXR: Distended loops of large bowel with air fluid levels No free air noted Abd. Sonar: Aperistaltic thickened loops of bowel in RFI No mass seen CT Abdomen: Fluid-filled large & small bowel loops Closely related bowel loops in RFI – bowel wall thickening No definite mass seen Sigmoidoscopy: Mass seen at recto-sigmoid junction – biopsy taken Histology: Rectal biopsy with extensive mucosal ulceration. Marked inflammatory cell infiltrate composed predominantly of chronic inflamm. cells and fibrin deposition Amoebae noted and confirmed with PAS stain. SPECIAL INVESTIGATIONS

  7. SUMMARY & MANAGEMENT • 2yr 10mo girl with • Immunosuppression • Amoebic proctitis and a chronic inflammatory mass at the recto-sigmoid junction consistent with an amoeboma. • Treated with oral Metronidazole • Optimized general condition in terms of nutrition • Referred for initiation of HAART

  8. AMOEBIASIS

  9. The Organism • 4 species of Entamoeba: • Nonpathogenic: E. dispar, E. coli, E. hartmanni • Pathogenic: E. histolytica • amoebiasis = A Parasitic infection caused by the protozoon Entamoeba histolytica • 2nd to Malaria as protozoan cause of death worldwide • 10% of world’s population infected – Increased prevalence in developing countries (up to 25%) • In SA – More common in KZN • Factors contributing to faecal-oral spread: • Poor education • Poverty and overcrowding • Unsanitary conditions • HIV infection

  10. 1. Cyst Stage Infective stage Survive from –4 to 40 Celcius Size – 12mm Quadrinucleated Ingested by contact with fecally contaminated food Passes through stomach, excysts in lower small bowel. Metacystic amoeba with four cystic nuclei from each cyst 8 Small trophozoites from each metacystic amoeba Trophozoites carried to cecum The Life Cycle

  11. The Trophozoite Stage: 10-40 qm, fragile Uninucleate Erythrophagocytosis Reside, feed and multiply by binary fission in lumen of colon May invade – Lytic & physical mechanisms and metastasize to liver and other extra-intestinal sites Galactose-containing molecules & receptors regulate cyst formation Precyst – Cyst – Uninucleate to Quadrinucleate and passed in stool The Life Cycle

  12. The Pathogenesis • 10% of infected individuals develop invasive disease • Factors contributing to developing invasive disease: • Pathogenicity of infecting Entamoeba species • Dose of inoculum • Host factors: Impaired cell-mediated immunity, on steroids • Virulence of infecting species: • Presence of surface adhesion factors • Release of proteolytic enzymes • Release of cytotoxins and inflicting of cytolysis

  13. The Pathogenesis • Trophozoites adhere to colonic mucosal glycoproteins via a galactose and N-acetyl-D-galactosamine-specific lectin. • (Gal/GalNac) – Lectin is 260kD-surface protein consisting of a 225kD subunit and a 35kD subunit. • Adherence results in cell lysis (apoptosis) and PMN invasion • PMN’s are then lysed releasing lytic enzymes, causing more tissue destruction • Small foci of necrosis in the intestinal wall coalesce to form ulcers (Flask-shaped ulcers) • Parasites resist destruction by complement arm of immune system via Gal/GalNac mediated inhibition of the membrane attack complex • Cell-mediated immunity is important in clearing infection through generating Ұ-INF and TNF-α to activate macrophages and neutrophils to kill the trophozoite

  14. Area most commonly involved = Cecum, then Recto-sigmoid area May invade blood vessels causing thrombosis, infarction and dissemination via portal circulation to liver and extra-intestinal sites eg. brain, pleura, pericardium and genito-urinary system. Flask-shaped ulcers The Pathogenesis

  15. The Clinical Features • Many infections = Asymptomatic ‘cyst passers’ • Symptomatic infections may have a gradual, acute or rapid, fulminant course. • Clinical incubation period = 4 days to several months • Oftengradual development of symptoms = Irregular bouts of diarrhoea, abdominal pain, weight loss, nausea, loss of appetite (amoebic proctocolitis) • Less often sudden onset of copious diarrhoea containing mucus and blood. • Findings may include low-grade fever, tenderness on palpation of the abdominal wall overlying involved large bowel.

  16. The Complications • Complications of Intestinal amoebiasis: • Fulminant Amoebic Colitis with Perforation • May have a mortality rate of up to 50% • Children less than 2 yrs at increased risk of perforation • Massive Haemorrhage • Due to vasculitis of large arteries or multiple ulcers leading to small arterial leaks • amoebomas • A granulomatous thickening of the colon resulting from lytic necrosis followed by secondary pyogenic inflammation, leading to fibrosis and proliferative granulation tissue. Lesions are firm, hard, may resemble a carcinoma. • amoebic Stricture • Resulting from fibrosis of intestinal wall. Can involve rectum, anus or sigmoid.

  17. The Complications • Complications of Extra-Intestinal Amoebiasis: • Amoebic Liver Abcess • Most frequent complication of amoebiasis • Male:Female Ratio = 1 in Children and infants • In adulthood = More common in young males • Third to Half may have no history of diarrhoea • Commonly found in Right Lobe of liver • Presents acutely with high fever, RUQ tenderness • Jaundice an unusual finding • Have marked leucocytosis and may have XR abnormalities in 25 to 90% of patients

  18. The Complications • Complications of Extra-Intestinal amoebiasis: • amoebic Peritonitis • As a complication of a ruptured hepatic abcess • Pleuropulmonary amoebiasis • Caused by rupture of Rt. Lobe Liver abcess in 10% of patients • Has cough, pleuritic chest pain & dyspnoea • amoebic Pericarditis • Rare, but most serious complication in 3% of pts. with liver involvement • Rupture of Left Lobe liver abcess • Cerebral amoebiasis • Rare, has altered consciousness and focal neuro signs • CT – Irregular lesions without surrounding capsule or enhancement • Genito-Urinary Involvement • Painful genital ulcers – Punched out appearance & profuse discharge

  19. The Diagnosis • Light Microscopy of Stool • Identification of trophozoites / cysts in fresh stool • Disadvantages: • Not sensitive (miss up to two thirds of infections) • Cannot distinguish between E.histolytica and E. dispar • Serology: • Anti-amoebic antibodies (IgM) 70% sensitive for amoebiccolitis and 90% sensitive for amoebic liver abcess • Stool antigen-detection test or PCR • Sensitive and Specific • Disadvantages: • Antigen detection test (EIA) only available from Blacksburg VA

  20. The Diagnosis • Colonoscopy / Sigmoidoscopy • Colonoscopy preferable • Wet preps of material from ulcer-base can show trophozoites • Biopsies should be taken from edge of ulcers • Recommended to evaluate for amoebic colitis even when Ulcerative Colitis considered

  21. The Diagnosis • amoebic Liver Abcess: • Diagnosis relies on: • Detection of risk factors for E.histolytica infection • Positive Serology • Lesion in Liver : • Abdominal USS • Abdominal CT: Well-rounded, wall enhances • Aspiration may yield “anchovy-paste” material • More often yellow / gray-green • Often odourless and sterile – Highly suggestive of amoebicabcess

  22. The Management • Asymptomatic infections • Luminal agent only recommended but ?not available in SA • In general, not treated in endemic areas • Symptomatic infections • Oral Metronidazole for 10 days • Effective in eradicating amoebae in bowel lumen and wall • Effective in eradicating extra-intestinal disease • Additional luminal agent not necessary • E. dispar infection doesn’t require treatment

  23. Prevention • Improved sanitationandclean water supplyreducefecal-oral transmission • Boiling water, Washing veg with vinegar • Vaccination: • None available currently • Prototype subunit vaccines based on the Gal/GalNAc-lectin under study

More Related